This is the decade to find the solution for GDM screening and treatments.

The most common complication of pregnancy is diabetes. It is estimated that 1 in 6 pregnancies are affected (16.6%), with 84% of diabetic pregnancies being affected by Gestational Diabetes Mellitus (GDM)1 . More than 15 years ago, the evidence was clear that treatment of even mild GDM had beneficial effects on both maternal and neonatal outcomes2 . These findings were instrumental in encouraging clinicians to offer detection and intervention for GDM. The evidence is also accumulating linking maternal GDM with future disorders of maternal glucose metabolism and of increased childhood adiposity3, 4 . Identifying women with GDM is thus important for the health of the mother and infant in the index pregnancy but also for their future health to prevent non-communicable diseases (NCD).